Media & news

Evidence supporting TiUnite

by: Ruth Bloechlinger

Two recent studies demonstrate the superiority of TiUnite over machined implants at up to 9 years follow-up.

Evidence supporting TiUnite®

TiUnite outperforms machined implants in terms of survival and marginal bone remodeling in two recent long-term studies.1

Polizzi et al. (2013) retrospectively shows a CSR 96.6% for TiUnite compared to 90.3% for machined implants at 6–9 years and Rocci et al. (2013) demonstrates a CSR of 95.5% for TiUnite versus 85.5% for machined implants at 9 years. Both were statistically significant. TiUnite also demonstrated an advantage in terms of mean marginal bone remodeling in both studies, although statistically significant only in the study by Polizzi. After 9 years, TiUnite continues to outperform machined implants.

More to explore:

To read the abstracts of the studies, please click here and here.

To learn more about the TiUnite implant surface, please click here.

Looking to add to your skill set? Check out Nobel Biocare's global course catalog to find a training program near you.

 

References

1 Polizzi G, Gualini F, Friberg B. Int J Prosthodont. 2013 Jul–Aug;26(4):350–8. / Rocci A, Rocci M, Rocci C, Scoccia A, Gargari M, Martignoni M, Gottlow J, Sennerby L. Int J Oral Maxillofac Implants. 2013 May–Jun;28(3):891–5.